The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

Pharma Market Access Insights - from Mtech Access

Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022.
We were joined by some of Mtech Access’s closest and most insightful friends:
- David Thorne (Director, Mtech Access and Well Up North PCN) our Policy expert
- Patrick McGinley (Head of Costing and Service Line Reporting, Maidstone and Tunbridge Wells NHS Trust) our Hospitals and Finance expert
- Liz Cross (Advanced Nurse Practitioner, Attenborough Surgery, Watford) our Primary Care and Clinical expert
- Ewan Maule (Interim Chief Pharmacist, North East and North Cumbria ICS) our System and Medicines expert
This podcast was originally broadcast as a live webinar on 10th December 2021.
Learn more at https://mtechaccess.co.uk/evolving-nhs-pharma-medtech-support-2022/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

فصل ها

1. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion (00:00:00)

2. What's the most important thing that's happened in the NHS in 2021? (00:02:05)

3. What are the panel most looking forward to or dreading in 2022? (00:08:25)

4. Given the new ICS structures how might that impact on the formulary approach to procurement? (00:18:15)

5. How might QOF evolve to reduce health inequalities? (00:20:34)

6. How much is known about the budgetary and financial arrangements for next year (2022)? (00:24:50)

7. What essential data will be used at a system level to deliver the vision? (00:28:12)

8. How have you seen the patient experience change? (00:31:02)

9. Who should Pharma and Medtech be talking to about driving change in the NHS? (00:37:05)

10. Is there still a role for GP Federations? (00:44:47)

11. What do you make of community diagnostic hubs and how will they work in practice? (00:45:52)

12. What needs to happen for ICSs to take on specialised commissioning? (00:48:04)

13. How can industry help NHS Trusts and ICSs to shift the focus towards value based procurement instead of unit costs? (00:51:15)

14. What's of more value to the NHS: clinical and quality improvements or system and capacity improvements? (00:53:54)

15. What knowledge or capability would be most valuable to hear from an industry representative? (00:57:35)